MEDDIC vs MEDDPICC: Which One Actually Helps You Close

For MEDDIC vs MEDDPICC, use MEDDIC when the buying path is straightforward and MEDDPICC when contracts, approvals, or competing options create separate risks. My default is MEDDIC, with MEDDPICC required for deals where choosing your product and getting permission to buy it are different jobs.

Neither framework closes anything by itself. Its job is to expose what you do not know early enough to act. A completed qualification form is not a purchase order, despite what the forecast meeting sometimes implies.

What does each letter actually buy you?

MEDDIC covers six areas. MEDDPICC keeps those areas and adds Paper process and Competition. The additional P goes after Decision process; the additional C goes after Champion.

The definitions matter less than the evidence each letter should produce:

• Metrics: The measurable improvement the buyer expects. Establish the current state, the desired change, and how the buyer will measure it. A seller-built ROI estimate is a starting point, not buyer agreement.
• Economic buyer: The person with authority to approve the spend and accept the tradeoff. Find out what they need to believe before approving. A senior title alone does not establish budget authority.
• Decision criteria: The requirements buyers will use to compare options. Separate genuine requirements from preferences, and learn who can change them. Your sales engineer needs this before building another custom demo.
• Decision process: How the organization will evaluate options and make a choice. Identify the people, meetings, dependencies, and decision owner. A demo followed by internal discussion is not enough detail.
• Identify pain: The business problem and the consequence of leaving it alone. Connect the problem to a priority someone owns. Some MEDDPICC implementations call this Implicate pain, emphasizing those consequences.
• Champion: Someone with influence who benefits from the change and actively sells it internally. Look for actions: sharing internal objections, arranging access, or helping shape the business case. Responsiveness is pleasant. It is not influence.
• Paper process, MEDDPICC only: The steps required to turn a decision into an executable purchase. Map contract review, vendor setup, purchasing approvals, signatory authority, and their sequence.
• Competition, MEDDPICC only: The alternatives competing for the decision or resources. Include another vendor, an internal build, another initiative, and doing nothing.

Which differences should decide your choice?

The useful MEDDIC vs MEDDPICC comparison is about how deals fail, not how many fields your CRM supports.

Buying condition	Pick	Why
One owner can approve and execute the purchase	MEDDIC	Decision process can cover the short approval path.
Product selection and purchasing follow separate workflows	MEDDPICC	Paper process needs its own owner and evidence.
Several vendors or internal initiatives are being evaluated	MEDDPICC	Competition needs explicit discovery and a response.
Early prospecting with limited buyer access	MEDDIC as a starting map	Establish pain and a credible next step before demanding full qualification.

Do not choose solely by account size. A large organization can have a simple departmental purchase. A smaller organization can require several approvals and a founder's final signature.

Do not choose by sales-cycle length alone, either. A stalled deal may have no buying process at all. Giving it more letters will not create one.

Where do paper process and competition earn their place?

Consider a hypothetical software deal. The team prefers your product, your champion has built support, and the economic buyer agrees the problem deserves funding.

Under a shallow review, that sounds ready to close. Under MEDDPICC, there are still separate questions to answer.

Paper process tests whether the purchase can happen on the expected timeline. Ask the buyer to walk through a recent, comparable purchase. Establish:

• Who starts contract review and vendor setup.
• Which steps can run together and which must happen in sequence.
• Who approves the purchase and who signs.
• What the seller must provide before each step can start.

Then put those steps into a shared buying plan with named owners. If nobody knows how purchasing starts, the close date is a preference.

Competition tests whether this purchase wins against the buyer's actual alternatives. Ask what happens if the team keeps its current setup. Find out whether another initiative could take the available budget or implementation capacity.

This changes your response. Against another vendor, you may need a focused evaluation tied to decision criteria. Against doing nothing, another feature demo is usually wasted effort. You need buyer-supported consequences of delay and a reason to act now.

These risks exist in MEDDIC deals too. MEDDPICC makes them harder to bury inside a broad decision-process note.

How do you stop qualification becoming CRM theater?

Require evidence and action, not populated fields.

For each material qualification area, capture:

• Evidence: What the buyer confirmed or did.
• Source: Who supplied it and whether they own that part of the purchase.
• Gap: What remains unknown or contradictory.
• Next action: How you will test it, with an owner and agreed timing.

For Economic buyer, recording a job title proves very little. Recording that the budget owner reviewed the business case, challenged an assumption, and agreed to an approval step is useful.

For Champion, test whether your contact will help you reach the people required to buy. If they cannot, coach them or build another relationship. Do not punish them for failing a test you never explained.

In deal reviews, managers should ask what changed and which unresolved risk could stop the purchase. Then decide the next move. Reading every CRM field aloud is an expensive way to establish that everyone can read.

Treat unknowns differently from negative evidence. Not knowing the signatory early in discovery is normal. Reaching the expected signature week without knowing the signatory is a forecast problem.

RevOps should keep field definitions consistent and let reps attach evidence where it already lives. SDRs should pass useful discovery, not guess the full buying committee. AEs own the deal map; sales engineers help validate criteria and evaluation results.

How should you roll out the framework?

Start with the failure pattern you need to fix. Review lost, stalled, and slipped deals using buyer evidence, not just loss-reason dropdowns.

If the recurring problem is weak pain, no budget authority, or friendly contacts mistaken for champions, implement MEDDIC well before adding more required fields. Extra categories will not repair shallow discovery.

If qualified deals repeatedly stall after selection, make Paper process explicit. If buyers repeatedly choose another priority or stay put, make Competition explicit. Use MEDDPICC for those opportunities and coach the corresponding buyer conversations.

Keep the same core definitions across both. A rep should not need to relearn what a champion means because an opportunity moved into a different segment.

FAQ

Is MEDDPICC better than MEDDIC?

MEDDPICC is better when purchasing steps and competing alternatives need separate attention. MEDDIC is sufficient when the buying path is simple and those risks can be covered clearly within the core qualification. More detailed documentation only helps if it changes the seller's actions.

Can you switch from MEDDIC to MEDDPICC during a deal?

Yes. Add Paper process and Competition as explicit workstreams when discovery reveals separate purchasing approvals or a meaningful alternative. Keep the existing evidence and investigate the new gaps rather than restarting qualification.

Which framework should our sales team choose?

Choose MEDDIC as the default for teams selling through straightforward buying paths. Require MEDDPICC where selection, purchasing, and competition involve distinct owners or decisions. For complex enterprise selling, I would use MEDDPICC from the start because those separate risks deserve separate inspection.